Date: 2016-08-23
Type of information: Nomination
Compound:
Company: Gilead Sciences (USA - CA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On August 23, 2016, Gilead Sciences announced that Kelly A. Kramer has been appointed to the company's Board of Directors and Audit Committee. Ms. Kramer is currently Executive Vice President and Chief Financial Officer of Cisco Systems, Inc. , which designs and sells products, services and solutions to securely connect everyone and everything. She previously served for 20 years in senior finance positions at General Electric , including as Chief Financial Officer of GE Healthcare's Healthcare Systems Business. She is a member of the board of the Silicon Valley Chapter of City Year , a non-profit organization that provides educational support for at-risk students in poor communities.
Financial terms:
Latest news:
